New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

Johnson & Johnson said the Food and Drug Administration approved its treatment of locally-advanced or metastatic non-small cell lung cancer for adults. The treatment, called Rybrevant, has been ...

Panelists discuss how the TROPION-Lung01 study results presented at World Conference on Lung Cancer 2024 shed light on ...

Panelists discuss how the HARMONi-02 trial presented at World Conference on Lung Cancer 2024 revealed key lung cancer insights, focusing on progression-free survival and immune-related response ...

We first told you about Lansing native Woody Ellis in September when he started his 2,000-mile journey across the country.

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...

In 2024, lung cancer is expected to account for 20% of cancer deaths, according to the National Cancer Institute. But ...

Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") announces that the University of Arizona Cancer Center (UACC) has been activated as the fifth clinical trial site in the Deltacel-01 ...

People aged 40 to 60 are seeing a worrying rise in cancer rates, despite past generations benefiting from modern medicine and ...

Dame Esther Rantzen's daughter, Rebecca Wilcox, has opened up on her mum's cancer battle as they continue to campaign for ...

Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...

A new Mount Sinai study published in the Journal of the National Cancer Institute on September 10, 2024, has found that ...